Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center unites innovative research and compassionate care to prevent and eliminate cancer and infectious disease. We’re driven by the urgency of our patients, the hope of our community, and our passion for discovery to pursue scientific breakthroughs and healthier lives for every person in every community.
In addition to bringing Seattle Cancer Care Alliance and Fred Hutch together as a single organization, we’ve strengthened our relationship with UW Medicine. While Fred Hutch is an independent, nonprofit organization, it will now also serve as the cancer program for UW Medicine. This unique relationship allows for enhanced care coordination with one of the world's leading integrated health systems.
Subscribe to Fred Hutch’s Oncology Insights e-newsletter to gain clinical and research insights from renowned experts.
Fred Hutchinson Cancer Center
Blinatumomab for Ph- ALL in First MRD-Negative Remission: E1910 and Beyond
- 283 views
- April 29, 2024
- 3
Fred Hutchinson Cancer Center
FDA Approval of Liso-Cel in R/R CLL: What You Need to Know
- 88 views
- March 26, 2024
Insights from 2023 ASH Annual Meeting
Clinically-Relevant Updates in ALL in Adults
- 54 views
- February 20, 2024
Insights from 2023 ASH Annual Meeting
Efficacy of Ibrutinib Arms Across ALPINE and ELEVATE-RR Trials in R/R CLL: A Matching-Adjusted Indirect Comparison
- 741 views
- December 19, 2023
- 1
Insights from 2023 ASH Annual Meeting
Impact of Ibrutinib Dose Reduction on Duration of Therapy in Patients With CLL/SLL
- 275 views
- December 19, 2023
- 1
Fred Hutchinson Cancer Center
MRD Positivity in ALL: Next Steps in Clinical Approach
- 257 views
- May 5, 2023
- 1
Fred Hutchinson Cancer Center
Surveying Safety and Efficacy Data in R/R CLL: ALPINE and ELEVATE-RR Trials
- 516 views
- March 23, 2023
- 2